Literature DB >> 18804497

Association analysis of nuclear receptor Rev-erb alpha gene (NR1D1) with mood disorders in the Japanese population.

Taro Kishi1, Tsuyoshi Kitajima, Masashi Ikeda, Yoshio Yamanouchi, Yoko Kinoshita, Kunihiro Kawashima, Tomo Okochi, Norio Ozaki, Nakao Iwata.   

Abstract

Several investigations have suggested that alterations in circadian rhythms may lay the foundation for the development of mood disorder (bipolar disorder and major depressive disorder). Recently, the nuclear receptor Rev-erb alpha was reported to be related to circadian rhythms, and was shown to be involved in the biological action of lithium in vitro. These evidences indicate that the nuclear receptor Rev-erb alpha gene (NR1D1) is a good candidate gene for the pathogenesis of mood disorders. To evaluate the association between NR1D1 and mood disorders, we conducted a case-control study of Japanese samples (147 bipolar patients, 322 major depressive disorder patients and 360 controls) with three tagging SNPs selected by HapMap database. One SNP showed an association with bipolar disorder in females. After Bonferroni correction for multiple testing, however, this significance disappeared. No significant association was found with major depressive disorder. In conclusion, our findings suggest that NR1D1 does not play a major role in the pathophysiology of mood disorders in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804497     DOI: 10.1016/j.neures.2008.08.008

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  18 in total

Review 1.  Clock gene variants in mood and anxiety disorders.

Authors:  Timo Partonen
Journal:  J Neural Transm (Vienna)       Date:  2012-04-27       Impact factor: 3.575

2.  Lack of association between MAGEL2 and schizophrenia and mood disorders in the Japanese population.

Authors:  Yasuhisa Fukuo; Taro Kishi; Tomo Okochi; Tsuyoshi Kitajima; Tomoko Tsunoka; Takenori Okumukura; Yoko Kinoshita; Kunihiro Kawashima; Yoshio Yamanouchi; Wakako Umene-Nakano; Hiroshi Naitoh; Toshiya Inada; Reiji Yoshimura; Jun Nakamura; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2010-05-14       Impact factor: 3.843

Review 3.  Chronobiology of bipolar disorder: therapeutic implication.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

4.  Circadian genes Period 1 and Period 2 in the nucleus accumbens regulate anxiety-related behavior.

Authors:  Sade Spencer; Edgardo Falcon; Jaswinder Kumar; Vaishnav Krishnan; Shibani Mukherjee; Shari G Birnbaum; Colleen A McClung
Journal:  Eur J Neurosci       Date:  2012-10-08       Impact factor: 3.386

5.  Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia.

Authors:  Hader A Mansour; Michael E Talkowski; Joel Wood; Kodavali V Chowdari; Lora McClain; Konasale Prasad; Debra Montrose; Andrea Fagiolini; Edward S Friedman; Michael H Allen; Charles L Bowden; Joseph Calabrese; Rif S El-Mallakh; Michael Escamilla; Stephen V Faraone; Mark D Fossey; Laszlo Gyulai; Jennifer M Loftis; Peter Hauser; Terence A Ketter; Lauren B Marangell; David J Miklowitz; Andrew A Nierenberg; Jayendra Patel; Gary S Sachs; Pamela Sklar; Jordan W Smoller; Nan Laird; Matcheri Keshavan; Michael E Thase; David Axelson; Boris Birmaher; David Lewis; Tim Monk; Ellen Frank; David J Kupfer; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Bipolar Disord       Date:  2009-11       Impact factor: 6.744

6.  Systematic analysis of circadian genes in a population-based sample reveals association of TIMELESS with depression and sleep disturbance.

Authors:  Siddheshwar J Utge; Pia Soronen; Anu Loukola; Erkki Kronholm; Hanna M Ollila; Sami Pirkola; Tarja Porkka-Heiskanen; Timo Partonen; Tiina Paunio
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

7.  HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort.

Authors:  Taro Kishi; Reiji Yoshimura; Tsuyoshi Kitajima; Tomo Okochi; Takenori Okumura; Tomoko Tsunoka; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Hiroshi Naitoh; Jun Nakamura; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2009-11-24       Impact factor: 3.843

8.  Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the Japanese population.

Authors:  Akiko Okuda; Taro Kishi; Tomo Okochi; Masashi Ikeda; Tsuyoshi Kitajima; Tomoko Tsunoka; Takenori Okumukura; Yasuhisa Fukuo; Yoko Kinoshita; Kunihiro Kawashima; Yoshio Yamanouchi; Toshiya Inada; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2009-09-04       Impact factor: 3.843

9.  CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients.

Authors:  Taro Kishi; Tsuyoshi Kitajima; Masashi Ikeda; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Tomo Okochi; Takenori Okumura; Tomoko Tsunoka; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2009-04-04       Impact factor: 3.843

10.  Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder.

Authors:  Virginia Soria; Erika Martínez-Amorós; Geòrgia Escaramís; Joaquín Valero; Rosario Pérez-Egea; Cecilia García; Alfonso Gutiérrez-Zotes; Dolors Puigdemont; Mònica Bayés; José M Crespo; Lourdes Martorell; Elisabet Vilella; Antonio Labad; Julio Vallejo; Víctor Pérez; José M Menchón; Xavier Estivill; Mònica Gratacòs; Mikel Urretavizcaya
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.